loading
Third Harmonic Bio Inc stock is traded at $12.38, with a volume of 35,096. It is up +2.60% in the last 24 hours and down -0.80% over the past month. Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
See More
Previous Close:
$12.11
Open:
$11.99
24h Volume:
35,096
Relative Volume:
0.20
Market Cap:
$509.61M
Revenue:
-
Net Income/Loss:
$-32.74M
P/E Ratio:
-7.8763
EPS:
-1.5718
Net Cash Flow:
$-24.89M
1W Performance:
-14.81%
1M Performance:
-0.80%
6M Performance:
+6.15%
1Y Performance:
+90.78%
1-Day Range:
Value
$11.99
$12.68
1-Week Range:
Value
$11.69
$14.82
52-Week Range:
Value
$5.765
$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name
Name
Third Harmonic Bio Inc
Name
Phone
(209) 727-2457
Name
Address
1700 MONTGOMERY STREET, SAN FRANCISCO
Name
Employee
42
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
THRD's Discussions on Twitter

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-16-22 Downgrade Jefferies Buy → Hold
Dec-15-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-10-22 Initiated Cowen Outperform
Oct-10-22 Initiated Jefferies Buy
Oct-10-22 Initiated Morgan Stanley Overweight

Third Harmonic Bio Inc Stock (THRD) Latest News

pulisher
Nov 04, 2024

(THRD) Technical Data - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 31, 2024

Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024
pulisher
Oct 30, 2024

Third Harmonic Bio's chief medical officer sells $40,095 in stock - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

A new biotech, built around protein design, springs from David Baker’s lab - BioPharma Dive

Oct 30, 2024
pulisher
Oct 24, 2024

Where are the Opportunities in (THRD) - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 14, 2024

(THRD) Trading Signals - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 10, 2024

Upstream prices $255M IPO in bid to challenge Amgen, AstraZeneca asthma drug - BioPharma Dive

Oct 10, 2024
pulisher
Oct 08, 2024

Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive

Oct 08, 2024
pulisher
Oct 07, 2024

Third Harmonic Bio: Nothing Stands Out (NASDAQ:THRD) - Seeking Alpha

Oct 07, 2024
pulisher
Oct 07, 2024

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney - BioPharma Dive

Oct 07, 2024
pulisher
Oct 03, 2024

How To Trade (THRD) - Stock Traders Daily

Oct 03, 2024
pulisher
Sep 30, 2024

Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com

Sep 30, 2024
pulisher
Sep 25, 2024

WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga

Sep 25, 2024
pulisher
Sep 22, 2024

Long Term Trading Analysis for (THRD) - Stock Traders Daily

Sep 22, 2024
pulisher
Sep 21, 2024

Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Third harmonic bio executive sells over $140k in stock - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

How the (HRMY) price action is used to our Advantage - Stock Traders Daily

Sep 20, 2024
pulisher
Sep 19, 2024

Hyliion Holdings Corporation [HYLN] Records 50-Day SMA of $2.01 - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

23andMe faces Nasdaq delisting - MSN

Sep 19, 2024
pulisher
Sep 19, 2024

Independent directors resign from 23andMe board after opposing move to privatize - Washington Times

Sep 19, 2024
pulisher
Sep 19, 2024

23andMe Stock Falls as All Board Members Resign - Barron's

Sep 19, 2024
pulisher
Sep 19, 2024

Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins

Sep 19, 2024
pulisher
Sep 19, 2024

Third Harmonic Bio Inc (THRD) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

ME STOCK ALERT: 23andMe Holding Co. Shareholders are - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

23andme board resigns : Turmoil at 23andMe: Board Resigns Amid Controversial Plans to Go Private - CGNEWS24

Sep 19, 2024
pulisher
Sep 19, 2024

23andme board resigns : 23andMe Board Resigns En Masse: A Fatal Blow to the DNA Testing Giant? - CGNEWS24

Sep 19, 2024
pulisher
Sep 19, 2024

Rhumbline Advisers Boosts Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Hex And PulseChain Founder Richard Heart In Hot Water With Finnish Authorities - Cryptonews

Sep 18, 2024
pulisher
Sep 18, 2024

23andMe Board Resigns in New Blow to DNA-Testing Company and CEO Anne Wojcicki - The Wall Street Journal

Sep 18, 2024
pulisher
Sep 18, 2024

Crypto Influencer Richard Heart Investigated for Tax Evasion - Crypto Times

Sep 18, 2024
pulisher
Sep 18, 2024

23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private - New York Post

Sep 18, 2024
pulisher
Sep 18, 2024

Check Out Hyliion Holdings Corporation (HYLN)’s Trade Data Rather Than the Analysts’ Views - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

A Look at Harmonic, Inc. (HLIT) Shares in the Recent Past Indicates Growth - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Finnish Police Seeking Hex Founder Richard Heart for Suspected Gross Tax Evasion, Assault - Decrypt

Sep 18, 2024
pulisher
Sep 18, 2024

Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time - Yahoo Finance

Sep 18, 2024
pulisher
Sep 18, 2024

23andMe’s stock tumbles 7% after independent directors quit in clash with CEO over buyout plan - MarketWatch

Sep 18, 2024
pulisher
Sep 18, 2024

23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid - MarketWatch

Sep 18, 2024
pulisher
Sep 18, 2024

23andMe down after independent directors quit board - XM

Sep 18, 2024
pulisher
Sep 17, 2024

Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - BNN Bloomberg

Sep 17, 2024
pulisher
Sep 17, 2024

Raymond James analysts upgrades a Strong buy rating for Harmonic, Inc. (HLIT) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs - BioPharma Dive

Sep 17, 2024
pulisher
Sep 17, 2024

Hyliion Holdings Corporation (HYLN) did well last session? - US Post News

Sep 17, 2024
pulisher
Sep 16, 2024

HashiCorp Inc (HCP) Becoming More Attractive for Investors - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business - Yahoo Finance

Sep 16, 2024
pulisher
Sep 14, 2024

Commonwealth Equity Services LLC Trims Stake in Haleon plc (NYSE:HLN) - Defense World

Sep 14, 2024

Third Harmonic Bio Inc Stock (THRD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Third Harmonic Bio Inc Stock (THRD) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Conner Edward R.
Chief Medical Officer
Oct 28 '24
Option Exercise
4.20
2,673
11,227
2,673
Conner Edward R.
Chief Medical Officer
Oct 28 '24
Sale
15.00
2,673
40,095
0
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):